ABSTRACT Caspofungin is an antifungal agent used for the treatment of severe fungal infections, which is semi‐synthesized from pneumocandin B 0 , a secondary metabolite produced by filamentous fungus Glarea lozoyensis . To identify new pneumocandin analogues, a chemical reinvestigation was carried out on G. lozoyensis . This endeavor resulted in the isolation of pneumocandin B 0 and two previously undescribed pneumocandin derivatives, designated as pneumocandins B 7 and B 8 . Their structures were elucidated using HRESIMS and NMR spectroscopic analyses. Pneumocandins B 7 and B 8 represent the first reported pneumocandin analogues with a hydroxylated 10,12‐dimethylmyristate (DMM) moiety. Antifungal activity assays revealed that pneumocandins B 7 and B 8 exhibited reduced antifungal efficacy across all eight tested Candida strains in comparison to pneumocandin B 0 . These findings suggest that the introduction of a hydroxyl group in the DMM moiety has a negative effect on the antifungal activity. These results enrich the structural diversity of the pneumocandin family and provide new insights into the structure‐activity relationship of pneumocandins.
Huang et al. (Mon,) studied this question.